Cannabis rescheduling, explained
Qualifying medical marijuana moved to Schedule III in April 2026. Federal dispensary registrations have begun, while adult-use marijuana remains Schedule I.
Last updated 2026-11-08 · Not legal advice
Federal cannabis policy now has two distinct tracks. April's rule covers FDA-approved marijuana drug products and marijuana subject to qualifying state medical-marijuana licenses. It did not move all cannabis to Schedule III. In late October, DOJ announced the first phase of federal medical-dispensary registrations. The separate proposal to reschedule the remaining marijuana is still an administrative proceeding.
Timeline
What the April rule changed
The order announced April 23 took effect when published April 28, 2026. Covered medical marijuana moved from Schedule I to Schedule III, with DEA registration and other federal controls. Marijuana outside the covered categories remains Schedule I. The rule also preserves import and export permit requirements; it is not unrestricted federal legalization.
Federal registrations are now being issued
On October 30, DOJ announced an initial phase covering more than 900 qualifying medical dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. State licensure does not automatically provide federal registration. Applicants must meet federal requirements, including DEA's pre-registration investigation. Manufacturer and distributor applications involve additional review.
What this means for taxes and research
The final rule says qualifying state medical-license holders are no longer subject to Section 280E's deduction restriction, which applies to Schedule I and II trafficking. It also says the rule does not determine any business's individual federal tax liability. Retrospective relief was encouraged for Treasury consideration, not automatically granted. Registered researchers may obtain covered products from state licensees holding valid federal registrations, subject to the rule.
Where the broader proceeding stands
The hearing actually ran from June 29 through July 15, 2026. An October 22 order admitted a GAO report, declined to reopen testimony and allowed supplemental briefs through October 29, with replies due November 5. Those procedural steps do not themselves reschedule additional marijuana. A hearing deadline should not be presented as an effective date for broader reform.
Pending applicants have separate conditions
DEA distinguishes registered businesses from timely applicants operating under the April order's conditional transition provisions. Its published applicant list is not a registration directory. Operators must confirm the authority of supply-chain partners and follow the applicable security, inventory and recordkeeping requirements.
Frequently asked questions
Is all marijuana federally legal now?
No. The April rule covers specified medical categories. DOJ says recreational marijuana and other activity outside those categories remain subject to Schedule I controls.
What is Schedule III?
It is a controlled-substance category with lower abuse potential than Schedules I and II. DEA describes its dependence potential as moderate to low. Classification does not remove the applicable federal handling requirements.
Does a state medical license count as DEA registration?
No. DOJ explicitly distinguishes state licensure from federal registration. Qualifying timely applicants may have conditional transition authority while their applications are pending; that is separate from approval.
Does appearing on DEA's applicant list prove approval?
No. The list identifies timely applicants. Confirm the business's registration or applicable pending-application authority directly; the list alone does not establish that a registration has been issued.
Does the rule automatically provide a past-year tax refund?
No. The rule encourages consideration of retrospective Section 280E relief and expressly avoids deciding individual federal tax liability. It does not itself award a refund.
When will the remaining marijuana move to Schedule III?
The reviewed official orders establish no effective date for a broader change. The completed hearing and subsequent briefing are steps in a separate proceeding. Watch for a final agency action and its effective date.
See where your state stands → cannabis laws by state, or browse cannabis jobs.
Sources: justice.gov, federalregister.gov, justice.gov, dea.gov, dea.gov, deadiversion.usdoj.gov, deadiversion.usdoj.gov, dea.gov. General information for adults 21+, not legal advice.